Vice President, Business Transactions at Formation Bio
📍 Red Bank, New Jersey, United States
Bob Silverman is a seasoned biopharma executive and the current Vice President of Business Transactions at Formation Bio. With a Juris Doctor from Boston University School of Law, his expertise lies in leveraging advanced technologies like AI and cell simulation for drug discovery. He has held Chief Business Officer roles at Turbine, C2i Genomics, and Rejuveron.
He is a registered patent attorney with a degree in Chemistry, a unique combination that underpins his extensive career in biopharma licensing and M&A.
Read the full overview →
Experience
3 Years
Current Role
Vice President, Business Transactions
Job Level
Senior
Location
Red Bank, New Jersey, United States
Personality Overview
How Bob shows up
Example Seeker
Assertive
Curious
They can sound friendly and charming but can quickly change gears to become inquisitive and probing. They ask a lot of questions and rely heavily on information and collaterals. They are generally good communicators and can be hard to convince.
Priorities
Topics Bob cares about
AI in Drug Discovery
His career focuses on companies using AI and cell simulation to guide biopharma R&D, from discovery at Turbine to clinical trials at Formation Bio.
Biopharma Deal-Making
An expert in business transactions, licensing, and M&A, with experience from multiple CBO roles and nearly three decades in partnering at Roche. He helped facilitate a collaboration between ModeX and Merck.
+5 more topicsLogin to view topics
Career
Work history
7-2025
Vice President, Business Transactions
Formation Bio
9-2023 - 4-2025
Chief Business Officer
Turbine
7-2023 - 12-2023
Business Consultant to the CEO
C2i Genomics (acquired by Veracyte Jan 2024)
1-2023 - 6-2023
Chief Business Officer
C2i Genomics
7-2021 - 12-2022
Chief Business Officer
Rejuveron Life Sciences AG
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.